Intranasal Drug Delivery Devices Market 2024| Global Industry Analysis Report | |
The Intranasal Drug Delivery Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033). Learn More On The Intranasal Drug Delivery Devices Market: https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report As per The Business Research Company’s Intranasal Drug Delivery Devices Global Market Report 2024, the market for intranasal drug delivery devices has exhibited robust growth in recent times, ascending from $55.27 billion in 2024 to $60.27 billion in 2024, denoting a notable compound annual growth rate (CAGR) of 9.0%. This growth trajectory in the historical period is attributable to several factors including the escalation of chronic respiratory ailments, heightened patient preference and compliance, the convenience associated with self-administration, burgeoning pediatric applications, and the expanded market presence in allergic rhinitis treatment, along with a broader spectrum of indications. The increasing prevalence of chronic diseases is expected to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases can be defined as conditions that last 1 year or more and require ongoing medical attention, limit activities of daily living, or both. Intranasal drug delivery devices are used to manage chronic diseases by providing a non-invasive and efficient way to administer medications. They allow medications to be delivered directly to the affected area, which is convenient, making it easy to use and promoting rapid absorption. For instance, in September 2022, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2024, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market. Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp The intranasal drug delivery devices market covered in this report is segmented – 1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products 2) By Dosage: Unit-Dose, Multi-Dose 3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications 4) By End User: Hospitals, Clinics, Homecare, Other End Users Prominent pharmaceutical entities operating within the nasal drug delivery technology arena are actively engaged in the development of novel and enhanced products, aiming to furnish their clientele with innovative means of drug administration to fortify their market positioning. A case in point is AptarGroup, Inc., a US-based enterprise specializing in drug delivery and pharmaceuticals, which recently introduced APF Futurity, the inaugural recyclable, metal-free, multidose nasal spray. Designed to dispense nasal saline and equivalent over-the-counter (OTC) formulations, APF Futurity is crafted from polyolefin materials, devoid of any metal constituents or recycling disruptors. This innovative design not only reduces the need for segregation in recycling streams but also fosters a higher grade of recycled materials. Notably, APF Futurity has garnered Class AA certification from cyclos-HTP for recycling streams in Europe, owing to its highly recyclable nasal spray pump design, thus exemplifying a commitment towards sustainability and environmental stewardship. The intranasal drug delivery devices market report table of contents includes: 1. Executive Summary 2. Intranasal Drug Delivery Devices Market Characteristics 3. Intranasal Drug Delivery Devices Market Trends And Strategies 4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario 5. Global Intranasal Drug Delivery Devices Market Size and Growth ..... 32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking 33. Global Intranasal Drug Delivery Devices Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market 35. Intranasal Drug Delivery Devices Market Future Outlook and Potential Analysis 36. Appendix | |
| Target State: All States Target City : All Cities Last Update : Mar 20, 2024 3:27 AM Number of Views: 41 | Item Owner : TBRC Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |